Phase I study of a weekly schedule of a fixed dose of cisplatin and escalating doses of paclitaxel in patients with advanced oesophageal cancer.
Polee, M B
Phase I study of a weekly schedule of a fixed dose of cisplatin and escalating doses of paclitaxel in patients with advanced oesophageal cancer. [electronic resource] - European journal of cancer (Oxford, England : 1990) Jul 2002 - 1495-500 p. digital
Publication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't
0959-8049
10.1016/s0959-8049(02)00081-3 doi
Adenocarcinoma--drug therapy
Adult
Aged
Antineoplastic Combined Chemotherapy Protocols--administration & dosage
Carcinoma, Squamous Cell--drug therapy
Cisplatin--administration & dosage
Diarrhea--chemically induced
Dose-Response Relationship, Drug
Esophageal Neoplasms--drug therapy
Female
Hematologic Diseases--chemically induced
Humans
Infusions, Intravenous
Male
Maximum Tolerated Dose
Middle Aged
Nervous System Diseases--chemically induced
Paclitaxel--administration & dosage
Survival Analysis
Treatment Outcome
Phase I study of a weekly schedule of a fixed dose of cisplatin and escalating doses of paclitaxel in patients with advanced oesophageal cancer. [electronic resource] - European journal of cancer (Oxford, England : 1990) Jul 2002 - 1495-500 p. digital
Publication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't
0959-8049
10.1016/s0959-8049(02)00081-3 doi
Adenocarcinoma--drug therapy
Adult
Aged
Antineoplastic Combined Chemotherapy Protocols--administration & dosage
Carcinoma, Squamous Cell--drug therapy
Cisplatin--administration & dosage
Diarrhea--chemically induced
Dose-Response Relationship, Drug
Esophageal Neoplasms--drug therapy
Female
Hematologic Diseases--chemically induced
Humans
Infusions, Intravenous
Male
Maximum Tolerated Dose
Middle Aged
Nervous System Diseases--chemically induced
Paclitaxel--administration & dosage
Survival Analysis
Treatment Outcome